[HTML][HTML] Vaccine development against COVID-19: study from pre-clinical phases to clinical trials and global use

S Ahmed, S Khan, I Imran, F Al Mughairbi, FS Sheikh… - Vaccines, 2021 - mdpi.com
As per the World Health Organization (WHO), more than 288 vaccines against COVID-19
are being developed, with an estimated 184 being presently investigated in the pre-clinical …

[HTML][HTML] SARS-CoV-2 variants: a synopsis of in vitro efficacy data of convalescent plasma, currently marketed vaccines, and monoclonal antibodies

D Focosi, M Tuccori, A Baj, F Maggi - Viruses, 2021 - mdpi.com
We summarize here in vitro evidences of efficacy for convalescent plasma, currently
approved vaccines and monoclonal antibodies against SARS-CoV-2 variants of concern …

[HTML][HTML] SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell …

C Choy, J Chen, J Li, DT Gallagher, J Lu, D Wu… - Nature …, 2023 - nature.com
The resolution of SARS-CoV-2 replication hinges on cell-mediated immunity, wherein CD8+
T cells play a vital role. Nonetheless, the characterization of the specificity and TCR …

[HTML][HTML] Nature of Acquired Immune Responses, Epitope Specificity and Resultant Protection from SARS-CoV-2

RM Gorczynski, RA Lindley, EJ Steele… - Journal of Personalized …, 2021 - mdpi.com
The primary global response to the SARS-CoV-2 pandemic has been to bring to the clinic as
rapidly as possible a number of vaccines that are predicted to enhance immunity to this viral …

[HTML][HTML] COVID-19 vaccines: evidence, challenges and the future

E Tanzi, C Genovese, M Tettamanzi… - Journal of preventive …, 2021 - ncbi.nlm.nih.gov
Through an unprecedented research and development process, in early 2021, just one year
after the COVID-19 pandemic started devastating the world, there are several vaccines …

[HTML][HTML] Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in “real-world” settings

N Weng, G Pawelec - Immunity & Ageing, 2021 - Springer
The rapidity of SARS-CoV-2 vaccination around the world has substantially reduced the
number of new cases of COVID-19 and their severity in highly vaccinated countries. The …

Protection of hamsters challenged with SARS-CoV-2 variants of concern by two doses of MVC-COV1901 vaccine followed by a single dose of beta variant version of …

TY Kuo, CE Lien, YJ Lin, MY Lin, CC Wu, WH Tang… - bioRxiv, 2021 - biorxiv.org
The current fight against COVID-19 is compounded by the Variants of Concern (VoCs),
which can diminish the effectiveness of vaccines and potentially increase viral transmission …

Assessment of the post-SARS-CoV-2 vaccination response depending on the epidemiological status, demographic parameters and levels of selected cytokines in …

Z Bartuzi, T Rosada, N Ukleja-Sokołowska… - … in Dermatology and …, 2022 - termedia.pl
Results There were 18 convalescents among the respondents. A statistically significant
increase in the concentration of specific sIgG S1 in subsequent determinations was …

Evaluation of the CD4+ T cell response to SARS-CoV-2 infection and cross reactivity to beta variant in children of all ages

K Paul, F Sibbertsen, D Weiskopf, M Lütgehetmann… - medRxiv, 2022 - medrxiv.org
SARS-CoV-2 is still a major burden for global health despite effective vaccines. With the
reduction of social distancing measures, infection rates are increasing in children, while data …

[HTML][HTML] Impacto de la pandemia COVID-19 en la investigación y docencia en las nanociencias y la nanotecnología en México

GC Delgado Ramos, R Zanella… - Mundo nano. Revista …, 2021 - scielo.org.mx
Desde que en México se comenzaron a tomar medidas ante la pandemia COVID-19 en
marzo de 2020, los impactos sociales, económicos y políticos, y sus implicaciones en la …